Zumax Medical listed on the National Equities Exchange and Quotations (NEEQ); Dental Doctor completed the first phase of IPO coaching for the Shanghai Stock Exchange; the Chinese Stomatological Assoc…

Zumax Medical Listed on NEEQ Innovation Tier

On October 13, 2026, Suzhou Zumax Medical Technology Co., Ltd. was listed on the National Equities Exchange and Quotations (NEEQ) Innovation Tier under the securities code 875259. According to Zumax Medical's public transfer prospectus, the company reported operating revenue of RMB 354 million in 2025, net profit of RMB 56.133 million, with overseas sales accounting for 52.75%; dental surgical microscope revenue reached RMB 267 million, representing 75.53% of main business revenue, up 7.77% from RMB 248 million in 2024.

NMPA Issues "Toothpaste Classification Catalog," Effective May 1, 2027

On October 15, 2026, the National Medical Products Administration (NMPA) issued the "Toothpaste Classification Catalog," categorizing toothpaste efficacy into eight categories (01 basic cleaning, 02 caries prevention, 03 dental plaque inhibition, 04 anti-dentin hypersensitivity, 05 gingival problem relief, 06 stain removal and whitening, 07 anti-calculus, 08 halitosis relief), effective from May 1, 2027. Regarding target populations, products for children under 12 (inclusive) may only claim categories 01 and 02. Already-registered products must complete information changes before January 1, 2028. Toothpaste manufactured or imported before the change may be legally sold until the end of shelf life, provided there are no product quality or safety issues.

Chinese Stomatological Association Holds National Member Representative Election

On October 12, 2026, the 7th National Member Representative Congress of the Chinese Stomatological Association (CSA) was held in Shanghai, with nearly 300 member representatives from across the country in attendance. The CSA National Member Representative Congress holds leadership elections every five years. This congress elected 198 directors of the 7th Board of Directors, 5 supervisors of the 3rd Board of Supervisors, and 65 members of the Standing Council.

CSA Announces New Membership Criteria at CDS 2026, Plans to Reopen Membership Channel in November

Recently at CDS 2026 in Shanghai, the Chinese Stomatological Association announced new individual membership criteria and declared that the membership information management system will reopen in November 2026. General members now face additional professional technical qualification requirements; specialist members must have over 5 years of clinical experience and hold an intermediate or higher professional title or a master's degree; student membership has been expanded to include graduate students. The association had suspended new membership applications since December 9, 2024.

CSA Releases 16 Group Standards Covering Digital, Endodontic, Implant Restoration and Other Fields

On October 10, 2026, the Chinese Stomatological Association issued a notice (Kou Yi Hui Zi [2026] No. 12), releasing 16 group standards covering restoration, digital dentistry, implantology, endodontics and other fields, effective from November 1, 2026. The standards specify key technical requirements including anterior tooth restoration aesthetic indicators, digital model fabrication, dental implant robot application, and endodontic treatment guidelines, providing unified specifications for clinical practice. The full text concludes by noting that the designation of T/CHSA 120-2026 still contains conflicts and requires manual verification before publication.

China's First Group Standard for Oral AI Agent Technical Requirements Officially Released

Recently, the School of Stomatology at Anhui Medical University led a joint effort with 20 institutions including Peking University and Sichuan University to release the "Oral AI Agent Technical Requirements" group standard (T/ISC 0129-2026), covering functional requirements for oral AI agents in image recognition, assisted decision-making, consultation interaction, and document generation, as well as performance evaluation and security control requirements.

Dental Doctor Completes First Phase of SSE IPO Counseling: H1 Revenue RMB 940 Million, Up ~17% YoY

On October 8, 2026, Dongwu Securities issued a progress report on the first IPO counseling phase for Dental Doctor Medical Holding Group, disclosing H1 operating revenue of RMB 940 million, up 16.93% year-on-year, net profit attributable to shareholders of the parent company of RMB 90.9039 million, up 37.15%, and net cash flow of RMB 202 million, up 44.39% year-on-year. The report noted that the company has initiated IPO counseling procedures, though its governance structure still requires refinement. The report stated that the next counseling phase will continue to promote standardization of Dental Doctor's corporate governance, financial, and internal control systems and urge rectification.

BLT Plans to Invest RMB 1 Billion to Build Metal Additive Manufacturing Base

On October 8, the board of directors of Xi'an Bright Laser Technologies Co., Ltd. (BLT) approved a plan to invest approximately RMB 1 billion to build a metal additive manufacturing base in Taicang High-tech Zone, Jiangsu Province, with plans to acquire approximately 100 mu of land and construct a total floor area of approximately 104,000 square meters, with an estimated construction period of 24 months. In 2025, the company's 3D printing raw materials revenue reached RMB 113 million, up 24.80% year-on-year.

Drill-Free Caries Treatment Developer vVARDIS Files for US IPO, H1 2026 Revenue Up 214.2% YoY

On October 9, 2026, Swiss dental company vVARDIS Holding AG submitted an F-1 prospectus to the SEC, planning to list on the New York Stock Exchange. The company reported net revenue of USD 28.558 million in H1 2026, up 214.2% year-on-year, with a gross margin of 86.4%. Proceeds will be used for working capital, operating expenses, and capital expenditures.

Clear Aligner Brand Toothsi's Parent Company Secures INR 900 Million in Funding to Expand in India and Southeast Asia

On October 13, MakeO, the parent company of clear aligner brand Toothsi, announced it has secured INR 900 million (approximately RMB 63.26 million) in funding, led by Singularity AMC with participation from DSP Family Office and others. The funding will be used for offline store expansion in India and Southeast Asia, mergers and acquisitions, and upgrades to technology and manufacturing facilities. MakeO operates over 60 offline clinics, serves more than 400,000 consumers, and has combined business revenue exceeding INR 5 billion. The company has achieved EBITDA profitability and plans to double revenue within 2 to 3 years while continuing to expand.

Guangxi Medical University Affiliated Stomatological Hospital Develops First "AI Simultaneous Interpretation System for ASEAN Oral Medicine Exchange"

On October 12, during the 2026 "Vitality China Research Tour" Guangxi themed interview event organized by the Publicity Department of the CPC Central Committee, Kuang Hai, Deputy Party Secretary of the Affiliated Stomatological Hospital of Guangxi Medical University, introduced that the hospital led the development of the "AI simultaneous interpretation system for ASEAN oral medicine exchange," which supports real-time mutual translation of more than 10 Southeast Asian languages, helping ASEAN dental professionals conduct academic discussions and technical training. The hospital also uses an "AI + VR" virtual-real fusion simulated diagnosis and treatment system, enabling ASEAN dental doctors to simulate clinical operation scenarios through VR devices without crossing borders.

BEGO Permanent Restoration 3D Printing Hybrid Resin Approved by NMPA, Launched in China

Recently, BEGO's VarseoSmile® Crown plus hybrid resin received NMPA approval, registration number Guo Xie Zhu Jin 20263170356, suitable for light-curing 3D printing of permanent single crowns and veneers, with flexural strength of 116-150 MPa, available in 7 VITA classical shades and 1 bleach shade. The product has obtained US FDA 510(k) clearance and complies with EU MDR Class IIa requirements.

Dental 3D Printing Company SprintRay Launches Digital Dentistry Platform

On October 13, 2026, dental 3D printing company SprintRay launched its digital dentistry platform at the 3DNext 2026 conference, introducing the first wireless full-color intraoral scanner Foundation built for ScanOS, the companion scanning software ScanOS, and the Nano Series chairside printing, washing, and curing system occupying ≤72 cm of countertop space (including NanoPrint with a 385 nm light engine, NanoWash, and NanoCure), and partnered with GC to launch GRADIA® PREMi hybrid ceramic restorative resin. The platform has cumulatively produced over 20 million dental parts, with approximately 80% of chairside printing tasks involving a single patient.

Dental DSO Park Dental Partners Data Breach Triggers 4 Class Action Lawsuits

On October 13, 2026, Park Dental Partners disclosed in an 8-K filing with the SEC that unauthorized access to its computer network was discovered on August 28, 2026. The incident has triggered 4 state court lawsuits, with plaintiffs alleging that Park Dental failed to properly protect patient PHI, failed to implement reasonable security measures, resulting in the August data breach and increased identity theft risk, and further alleging the company failed to timely notify affected individuals.

New Data: US Dentist Economic Confidence Drops to 26% in Q3 2026, Lowest Since 2024

Recently, the ADA Health Policy Institute released the Q3 2026 "US Dental Economy" report, noting that US dentists' confidence in the overall economy dropped to 26.4%, the lowest in years; confidence in their own practices was 50.4%, and in the dental care industry 40.9%. During the same period, dental spending increased 0.5% quarter-over-quarter and declined 2.4% year-to-date. The report showed that 38% of dentists felt they were not busy enough, 8% felt too busy, and new patients waited an average of 12 days.

New Data: Global Dental Radiology Equipment Market CAGR of 5.8% from 2026-2035, China Among Key Markets

On October 11, 2026, IndexBox released a report stating that the global dental radiology equipment market will have a CAGR of 5.8% from 2026-2035, with the index rising from 100 in 2025 to approximately 176 by 2035. By end demand, clinics account for 55%, hospitals 20%, and imaging centers 10%; by region, Asia-Pacific accounts for 35%, North America 30%, and Europe 20%. The report noted that Asia-Pacific, North America, and Europe are the primary growth regions, with China and India identified as key markets. It also projected that industry concentration may further increase, with manufacturers increasing R&D investment in advanced imaging technologies.

New Study: hDPSC Secretome May Reduce Cerebral Infarct Volume, Aid Stroke Recovery

Recently, a team led by Kim Won-jae at Chonnam National University in South Korea administered Human Dental Pulp Stem Cell Secretome to a photothrombotic mouse ischemic stroke model, identifying 299 specific proteins that significantly reduced cerebral infarct volume, activated the Nrf2/HO-1 pathway, reduced inflammatory signals such as NF-κB, and decreased neuronal apoptosis. Behavioral tests (beam walking, rotarod, negative geotaxis, Barnes maze, etc.) showed improvements in motor coordination, spatial learning, and memory, with reduced anxiety-like behavior after stroke.

New Study: Ultrasound-Activated Piezoelectric Nanospheres May Enable Growth Factor-Free Pulp-Dentin Regeneration

Recently, Materials Today Bio reported that ultrasound-activated ZnO-incorporated bioactive glass nanospheres (Z-MBGNs) generated approximately 600 mV electrical signals in cell and mouse subcutaneous models, promoting odontogenic differentiation of Human Dental Pulp Stem Cells (hDPSCs), angiogenesis, and increasing collagen deposition to 56 times that of controls, with a scratch healing rate of 57.3%. The research remains at the proof-of-concept stage and requires further validation in in-situ dental models.